共 9 条
[1]
Remdesivir in Patients with Acute or Chronic Kidney Disease and COVID-19
[J].
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY,
2020, 31 (07)
:1384-1386
[2]
[Anonymous], 2020, KIDNEY INT KIDNEY INT KIDNEY INT KIDNEY INT KIDNEY INT KIDNEY INT KIDNEY INT KIDNEY INT KIDNEY INT KIDNEY INT KIDNEY INT KIDNEY INT KIDNEY INT KIDNEY INT KIDNEY INT KIDNEY INT KIDNEY INT KIDNEY INT KIDNEY INT KIDNEY INT KIDNEY INT KIDNEY INT KIDNEY INT KIDNEY INT KIDNEY INT KIDNEY INT KIDNEY INT KIDNEY INT KIDNEY INT KIDNEY INT KIDNEY INT KIDNEY INT KIDNEY INT KIDNEY INT KIDNEY INT KIDNEY INT KIDNEY INT KIDNEY INT KIDNEY INT KIDNEY INT KIDNEY INT KIDNEY INT KIDNEY INT KIDNEY
[3]
Acute Kidney Injury in COVID-19: Emerging Evidence of a Distinct Pathophysiology
[J].
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY,
2020, 31 (07)
:1380-1383
[4]
Update on the Burden of CKD
[J].
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY,
2017, 28 (04)
:1020-1022
[8]
Kidney Health Initiative, 2020, MAK CAS CHANG INCL P
[9]
U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) and Center for Biologics Evaluation and Research (CBER), 2020, COVID 19 DEV DRUGS B